TQB3454 tablets

DRUG4 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Acute Myeloid LeukemiaAdvanced Solid TumorsBiliary CarcinomaMyelodysplastic Syndromes

Phase 1

A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Biliary Carcinoma

Start: 2023-11-30End: 2023-12-31Target: 40Updated: 2023-11-18

A Study of TQB3454 Tablets in Patients With Blood Tumors

RecruitingNCT06218771

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Acute Myeloid Leukemia, Myelodysplastic Syndromes

Start: 2023-07-10End: 2025-12-31Target: 80Updated: 2024-01-23

Phase 2

Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors

Not yet recruitingNCT07738679

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Advanced Solid Tumors

Start: 2026-07-01End: 2029-09-01Target: 127Updated: 2026-07-31

Phase 3

A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.

Active, not recruitingNCT05987358

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Biliary Carcinoma

Start: 2023-09-21End: 2026-12-01Target: 165Updated: 2026-03-11